SCHW vs CME stock comparison
Schwab Charles vs. CME Group · data as of November 13, 2026
Schwab Charles (SCHW) has a market value of about $160.5B, CME Group (CME) about $113.8B. Over their latest twelve months Schwab Charles had revenue of $27.1B and CME Group $7.0B.
On our five checks Schwab Charles scores higher: 4.0 out of 5 (excellent) against 2.4 (weak).
By area, the stronger company is Schwab Charles on value; Schwab Charles on future growth; Schwab Charles on track record; CME Group on financial health; Schwab Charles on shareholder returns.
Schwab Charles is cheaper on earnings (P/E 15.9 vs. 26.1).
Schwab Charles leads on 19 of the compared lines and CME Group on 3.
Side by side
| SCHW | CME | |
|---|---|---|
| Size and price | ||
| Market cap | $160.5B | $113.8B |
| Share price | $92.98 | $317.97 |
| Score | ||
| Overall score (of 5) | 4.0 | 2.4 |
| Value | 4 | 0 |
| Future growth | 4 | 2 |
| Track record | 4 | 2 |
| Financial health | 3 | 4 |
| Shareholder returns | 5 | 4 |
| Valuation | ||
| P/E (TTM) | 15.9 | 26.1 |
| Forward P/E | 12.6 | 24.5 |
| Price / free cash flow | 13.7 | 26.3 |
| Price / sales | 5.9 | 16.3 |
| EV / EBITDA | — | 24.6 |
| PEG | 0.93 | 1.90 |
| DCF value vs. price | +20% | −41% |
| Business | ||
| Revenue | $27.1B | $7.0B |
| Net income | $10.3B | $4.4B |
| Free cash flow | $11.7B | $4.3B |
| Net margin | 37.9% | 63.3% |
| Gross margin (5-yr avg.) | — | — |
| ROIC (5-yr avg.) | — | 8.7% |
| Growth | ||
| Revenue growth (1 yr) | 22.0% | 6.4% |
| Revenue growth (5 yrs, per year) | 15.4% | 5.9% |
| EPS growth (5 yrs, per year) | 17.0% | 13.7% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | $12.8B | -$1.5B |
| Dividend yield | 1.38% | 1.64% |
| Shareholder yield | 6.0% | 1.6% |
| Analysts | ||
| Upside to average target | +25% | −0% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: SCHW TTM to September 30, 2026, CME TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Schwab Charles or CME Group?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Schwab Charles scores 4.0 out of 5 and CME Group 2.4; the table shows where each one is stronger.
Is Schwab Charles cheaper than CME Group?
On trailing earnings, Schwab Charles trades at a P/E of 15.9 and CME Group at 26.1, so Schwab Charles is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Schwab Charles or CME Group?
Over five years Schwab Charles grew revenue about 15.4% a year and CME Group about 5.9% a year.
Which pays a higher dividend?
Schwab Charles yields 1.38% and CME Group 1.64%.
Full Schwab Charles analysis → Full CME Group analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.